Carregant...
Carregant...

Vés al contingut (premeu Retorn)

Amygdalin analogs for the treatment of psoriasis

Autor
Perez, J.
Tipus d'activitat
Article en revista
Revista
Future Medicinal Chemistry
Data de publicació
2013-06-01
Volum
5
Número
7
Pàgina inicial
799
Pàgina final
808
DOI
https://doi.org/10.4155/fmc.13.27 Obrir en finestra nova
URL
http://www.future-science.com/toc/fmc/5/7 Obrir en finestra nova
Resum
Psoriasis is one of the most prevalent autoimmune illness worldwide. Several treatments are available depending on the extension of the psoriatic lesion. Among the topical treatments corticoids, vitamin D3 analogs and retinoids are commonly used. These treatments may have adverse effects in the long-term. On the other hand, systemic conventional treatments include immunosupresors like cyclosporine or methotrexate associated with high toxicity levels. Biologicals are alternative therapeutical ag...
Paraules clau
amygdalin, peptidomimetics, psoriasis
Grup de recerca
CEBIM - Centre de Biotecnologia Molecular
ENGMOL - Enginyeria Molecular

Participants